|
WO2021030207A1
|
|
Methods for peptide mass spectrometry fragmentation prediction
|
|
US2021002610A1
|
|
Methods for manufacturing t cells by direct sorting and compositions thereof
|
|
WO2020243134A1
|
|
Viral vectors and their use in adoptive cellular therapy
|
|
US2020318068A1
|
|
Use of retinoic acid in t-cell manufacturing
|
|
WO2020191172A1
|
|
Cd28 t cell cultures, compositions, and methods of using thereof
|
|
DE102019108125A1
|
|
CD28 T CELL CULTURES, COMPOSITIONS AND METHODS OF USE
|
|
CN111684062A
|
|
Method for producing T cell
|
|
DE102018108996A1
|
|
METHODS FOR MANUFACTURING AUTOLOGOUS T CELLS
|
|
DE102018108612A1
|
|
METHOD FOR INCREASING PERSISTENCE OF ADOPTIVELY INFUNDED T CELLS
|
|
DE102018100967A1
|
|
METHOD FOR DETERMINING THE EFFECTIVENESS OF VIRAL VECTORS
|
|
DE102018010282A1
|
|
Method for determining the effectiveness of viral vectors
|
|
DE102017127984A1
|
|
Method for the propagation and activation of γδ T cells
|
